Horizon Pharma plc
May 11, 2017

Horizon Pharma plc Announces Michelle Parsons as a 2017 Healthcare Businesswomen's Association Luminary

DUBLIN, Ireland, May 11, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Michelle Parsons, senior vice president, financial planning and analysis, has been named a 2017 Healthcare Businesswomen's Association (HBA) Luminary.  Michelle will be honored today at the 28th annual Woman of the Year event in New York.

The HBA is the leading not-for-profit global organization committed to furthering the advancement and impact of women in healthcare worldwide.  Michelle is being recognized for her commitment to advancing other women's careers through mentoring and sponsorship, as well as her 20-plus year dedication to the healthcare industry.

"It is an honor to be named a luminary by the Healthcare Businesswomen's Association," said Michelle Parsons, senior vice president, financial planning and analysis, Horizon Pharma plc.  "The growth and development of others is what I pride myself on and during my career, I have always focused on helping those around me reach their fullest potential.  I'm humbled to be a recipient of this award that honors passionate women in the industry."

Michelle joined Horizon Pharma in December 2014 as vice president, financial planning and analysis and was promoted to her current position in October 2015. During her long tenure in the pharmaceutical industry, she has held numerous leadership roles in financial systems, global planning and reporting.  Prior to joining Horizon Pharma, Michelle spent seven years at Fenwal, Inc. where she was the vice president of finance, responsible for directing her team in sales reporting, decision support and business operations. She also held roles at Fenwal as a director of global planning and reporting where she was responsible for transitioning the global business and implementing global systems, processes, and procedures.  Prior to Fenwal, Michelle spent 10 years at Dade Behring in several positions with increasing responsibility in finance and global operations.  She received a bachelor's degree in accounting from the Bloomsburg University of Pennsylvania in Bloomsburg, Penn.

"Michelle has been instrumental in Horizon's successes through her exceptional work at the helm of the financial planning and analysis team," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc.  "Michelle's outstanding leadership inspires those around her to take their work to the next level and on behalf of all of her colleagues, I congratulate Michelle on this important recognition."

About the Healthcare Businesswomen's Association (HBA)
The Healthcare Businesswomen's Association (HBA) is a global not-for-profit organization dedicated to furthering the advancement and impact of women in healthcare worldwide.  With 15 chapters throughout the US and in Europe, HBA serves a community of over 30,000 individuals and 100 Corporate Partners.  The HBA provides networking forums to build relationships; knowledge sharing and access to thought leaders to broaden perspective; educational programs to develop leadership skills and cutting edge industry knowledge and recognition of outstanding women and companies to promote visibility of their achievements.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

U.S. Media Contact:

Geoffrey Curtis

Senior Vice President, Corporate Affairs & Chief Communications Officer

media@horizonpharma.com

Primary Logo

Source: Horizon Pharma plc

News Provided by Acquire Media